{"title":"Non-pharmaceutical interventions and vaccination during COVID-19 in Canada: Implications for COVID and non-COVID outcomes","authors":"Mehdi Ammi , Zachary W. Desson , Maeva Z. Doumbia","doi":"10.1016/j.hlpt.2023.100801","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>As a federal country where health prerogatives are primarily at the subnational level (provinces), Canada has implemented non-pharmaceutical interventions (NPIs) of differing stringency and attained varied COVID-19 vaccination coverage across the different vaccination campaigns. NPIs and vaccination may have thus interacted in different ways.</p></div><div><h3>Methods</h3><p>A mixed-methods design combining a regression analysis and a comparative case study. The regression analysis focuses on COVID-19 outcomes such as COVID-19 cases, deaths, hospitalizations, and admissions in intensive care units. The case study centers on three provinces and explores outcomes beyond COVID-19, such as spillover on the healthcare system and the economy.</p></div><div><h3>Results</h3><p>While more stringent NPIs are associated with lower COVID outcomes, their interaction with vaccination coverage depends on the vaccination campaign. Increasing the vaccination coverage with more stringent NPIs was not associated with a decrease in COVID cases growth rate during the primary campaign (two-doses), however it was associated with a decrease in COVID hospitalizations during the booster campaign. For non-COVID outcomes, having less stringent restrictions and lower initial vaccination coverage did not help prevent longer wait times for healthcare nor higher initial unemployment.</p></div><div><h3>Conclusion</h3><p>The differing interaction between NPIs and vaccination coverage suggests that the interaction was more effective when the vaccine uptake was primarily from high-risk populations. Confirming this finding would require further detailed microdata analysis.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000771/pdfft?md5=632a501c6062c435f2af6e2dd0e9acde&pid=1-s2.0-S2211883723000771-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883723000771","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
As a federal country where health prerogatives are primarily at the subnational level (provinces), Canada has implemented non-pharmaceutical interventions (NPIs) of differing stringency and attained varied COVID-19 vaccination coverage across the different vaccination campaigns. NPIs and vaccination may have thus interacted in different ways.
Methods
A mixed-methods design combining a regression analysis and a comparative case study. The regression analysis focuses on COVID-19 outcomes such as COVID-19 cases, deaths, hospitalizations, and admissions in intensive care units. The case study centers on three provinces and explores outcomes beyond COVID-19, such as spillover on the healthcare system and the economy.
Results
While more stringent NPIs are associated with lower COVID outcomes, their interaction with vaccination coverage depends on the vaccination campaign. Increasing the vaccination coverage with more stringent NPIs was not associated with a decrease in COVID cases growth rate during the primary campaign (two-doses), however it was associated with a decrease in COVID hospitalizations during the booster campaign. For non-COVID outcomes, having less stringent restrictions and lower initial vaccination coverage did not help prevent longer wait times for healthcare nor higher initial unemployment.
Conclusion
The differing interaction between NPIs and vaccination coverage suggests that the interaction was more effective when the vaccine uptake was primarily from high-risk populations. Confirming this finding would require further detailed microdata analysis.
期刊介绍:
Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments.
HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.
Topics covered by HPT will include:
- Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems
- Cross-national comparisons on health policy using evidence-based approaches
- National studies on health policy to determine the outcomes of technology-driven initiatives
- Cross-border eHealth including health tourism
- The digital divide in mobility, access and affordability of healthcare
- Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies
- Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies
- Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making
- Stakeholder engagement with health technologies (clinical and patient/citizen buy-in)
- Regulation and health economics